Literature DB >> 26753765

Erratum to: KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin in prostate cancer models.

Giovanni Luca Gravina1, Andrea Mancini1, Patrizia Sanita1, Flora Vitale1, Francesco Marampon1, Luca Ventura2, Yosef Landesman3, Dilara McCauley3, Michael Kauffman3, Sharon Shacham3, Claudio Festuccia4.   

Abstract

Entities:  

Year:  2016        PMID： 26753765      PMCID： PMC4707722          DOI： 10.1186/s12885-015-2046-7

Source DB:  PubMed          Journal:  BMC Cancer        ISSN： 1471-2407            Impact factor:   4.430


× No keyword cloud information.
Unfortunately, the original version of this article [1] contained a mistake. The word ‘survivin’ in the title was incorrectly included as ‘surviving’. The title has been corrected above and in the original article.
  1 in total

1.  KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin [corrected] in prostate cancer models.

Authors:  Giovanni Luca Gravina; Andrea Mancini; Patrizia Sanita; Flora Vitale; Francesco Marampon; Luca Ventura; Yosef Landesman; Dilara McCauley; Michael Kauffman; Sharon Shacham; Claudio Festuccia
Journal:  BMC Cancer       Date:  2015-12-01       Impact factor: 4.430
  1 in total
  1 in total

1.  SNCA, a novel biomarker for Group 4 medulloblastomas, can inhibit tumor invasion and induce apoptosis.

Authors:  Yong-Xiao Li; Zhen-Wei Yu; Tao Jiang; Li-Wei Shao; Yan Liu; Na Li; Yu-Feng Wu; Chen Zheng; Xiao-Yu Wu; Ming Zhang; Dan-Feng Zheng; Xue-Ling Qi; Min Ding; Jing Zhang; Qing Chang
Journal:  Cancer Sci       Date:  2018-02-20       Impact factor: 6.716
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.